94 related articles for article (PubMed ID: 16734340)
1. [Biological characterization and prospects of application of a new bifidobacterial strain as an ingradient of probiotics].
Bovkun GF; Ivanov IIu; Pospelova VV; Aleshkin VA; Afanas'ev SS; Lakhtin VM; Levchenko TA
Vestn Ross Akad Med Nauk; 2006; (3):26-31. PubMed ID: 16734340
[TBL] [Abstract][Full Text] [Related]
2. [The primary screening of bifidobacteria and lactobacilli strains to develop effective probiotic preparations based on them].
Pikina AP; Smeianov VV; Efimov BA; Baĭnov NA; Brook I; Reeves G; Korshunov VM
Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):34-8. PubMed ID: 10876846
[TBL] [Abstract][Full Text] [Related]
3. [Antagonistic properties of bifidobacteria isolated from different natural sources].
Poltavs'ka OA; Kovalenko NK
Mikrobiol Z; 2005; 67(2):70-80. PubMed ID: 16018219
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect.
Presti I; D'Orazio G; Labra M; La Ferla B; Mezzasalma V; Bizzaro G; Giardina S; Michelotti A; Tursi F; Vassallo M; Di Gennaro P
Appl Microbiol Biotechnol; 2015 Jul; 99(13):5613-26. PubMed ID: 25744647
[TBL] [Abstract][Full Text] [Related]
5. Insights into the taxonomy, genetics and physiology of bifidobacteria.
Ventura M; van Sinderen D; Fitzgerald GF; Zink R
Antonie Van Leeuwenhoek; 2004 Oct; 86(3):205-23. PubMed ID: 15539925
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates.
Delgado S; O'Sullivan E; Fitzgerald G; Mayo B
J Appl Microbiol; 2008 Apr; 104(4):1119-27. PubMed ID: 18248372
[TBL] [Abstract][Full Text] [Related]
8. Novel bifidobacteria strains isolated from nonconventional sources. Technological, antimicrobial and biological characterization for their use as probiotics.
Sarquis MA; Siroli L; Modesto M; Patrignani F; Lanciotti R; Mattarelli P; Reinheimer J; Burns P
J Appl Microbiol; 2019 Oct; 127(4):1207-1218. PubMed ID: 31260157
[TBL] [Abstract][Full Text] [Related]
9. [The antagonistic activity of bifidobacteria in vitro and in vivo studied by using gnotobiological technology].
Korshunov VM; Urtaeva ZA; Smeianov VV; Efimov BA; Sarkisov SE; Krymshokalova ZA; Baĭnov NA; Pikina AP; Korshunova OV
Zh Mikrobiol Epidemiol Immunobiol; 1999; (5):72-7. PubMed ID: 10852027
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates.
Strompfová V; Lauková A
Anaerobe; 2014 Oct; 29():108-12. PubMed ID: 24239978
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of Bifidobacterium strains of human origin for potential use in probiotic functional foods.
Souza TC; Silva AM; Drews JR; Gomes DA; Vinderola CG; Nicoli JR
Benef Microbes; 2013 Jun; 4(2):179-86. PubMed ID: 23443950
[TBL] [Abstract][Full Text] [Related]
12. [New Approaches for the Isolation of Bifidobacterial Strains, Their Molecular Characterization, and Assessment of Their Probiotic Potential].
Kharchenko NV; Cherdyntseva TA; Netrusov AI
Mikrobiologiia; 2015; 84(3):352-9. PubMed ID: 26263695
[TBL] [Abstract][Full Text] [Related]
13. Effect of production conditions on the stability of a human bifidobacterial species Bifidobacterium longum in yogurt.
Abe F; Tomita S; Yaeshima T; Iwatsuki K
Lett Appl Microbiol; 2009 Dec; 49(6):715-20. PubMed ID: 19818009
[TBL] [Abstract][Full Text] [Related]
14. Probiotic properties of lactic acid bacteria isolated from stool samples of longevous people in regions of Hotan, Xinjiang and Bama, Guangxi, China.
Gu RX; Yang ZQ; Li ZH; Chen SL; Luo ZL
Anaerobe; 2008 Dec; 14(6):313-7. PubMed ID: 18634896
[TBL] [Abstract][Full Text] [Related]
15. Screening of Bifidobacterium strains isolated from human faeces for antagonistic activities against potentially bacterial pathogens.
Bevilacqua L; Ovidi M; Di Mattia E; Trovatelli LD; Canganella F
Microbiol Res; 2003; 158(2):179-85. PubMed ID: 12906392
[TBL] [Abstract][Full Text] [Related]
16. Complete genome sequence of Bifidobacterium longum KCTC 12200BP, a probiotic strain promoting the intestinal health.
Kwon SK; Kwak MJ; Seo JG; Chung MJ; Kim JF
J Biotechnol; 2015 Nov; 214():169-70. PubMed ID: 26439427
[TBL] [Abstract][Full Text] [Related]
17. Induction of acid resistance in Bifidobacterium: a mechanism for improving desirable traits of potentially probiotic strains.
Collado MC; Sanz Y
J Appl Microbiol; 2007 Oct; 103(4):1147-57. PubMed ID: 17897220
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterisation of an oxygen, acid and bile resistant Bifidobacterium animalis subsp. lactis Qq08.
Li Q; Chen Q; Ruan H; Zhu D; He G
J Sci Food Agric; 2010 Jun; 90(8):1340-6. PubMed ID: 20474053
[TBL] [Abstract][Full Text] [Related]
19. Use of D(acid)-, D(bile)-, z(acid)-, and z(bile)-values in evaluating Bifidobacteria with regard to stomach pH and bile salt sensitivity.
Jia L; Shigwedha N; Mwandemele OD
J Food Sci; 2010; 75(1):M14-8. PubMed ID: 20492180
[TBL] [Abstract][Full Text] [Related]
20. Complete genome sequence of Bifidobacterium adolesentis BBMN23, a probiotic strain from healthy centenarian.
Liu S; Zhao L; Ren F; Sun E; Zhang M; Guo H
J Biotechnol; 2015 Mar; 198():44-5. PubMed ID: 25678139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
